THE Pharmaceutical Society of New Zealand (PSNZ) has announced it will appoint a young pharmacist to its National Executive board for a trial period in an attempt to identify and encourage young leaders.
PEOPLE with obesity who take glucagon-like peptide-1 receptor agonists (GLP-1RAs) have a reduced risk of cancer compared to those not using those medications, according to US research published today in JAMA Oncology.
PHARMACISTS from across Australia recently came together for the Pharmacy Snow Business Conference at Mt Buller, sharing a passion for skiing alongside their commitment to professional development.
PHARMX Technologies yesterday announced strong results for the financial year ending 30 Jun 2025, with total revenues of $7.5 million, up 13% on the previous corresponding period.
Notifications
